Optimal Treatment for Hypertension in Patients at Risk for Cardiovascular Disease: A New Perspective
Frank A. Laws, M.D.
, and Richard W. Smalling, M.D., Ph.D.
Dr. Laws is from the Division of Cardiology, Department of Medicine, The University of Texas Medical School at Houston and Memorial Hermann Hospital, Houston, Texas.
During the past three years, Dr. Smalling has received grant/research support from Centocor, Cordis, Boston Scientific and Merck. Dr. Laws reports no commercial conflict of interest.
This activity is made possible by an unrestricted educational grant from
Estimated time to complete:
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing medical
education for physicians.
Upon completion of this Cyberounds®
, you should be able to:
- Identity which parameter of blood pressure yields the best prognostic information in hypertensive patients at risk for cardiovascular disease
- Identify the blood pressure profiles that represent the best therapeutic goals in hypertensive patients who are at risk for the development of cardiovascular disease
- Discuss why evaluation of other indices of arterial load and stiffness can lead to the early identification and treatment of patients at risk for the development of cardiovascular disease.